The rollout of the Pfizer/BioNTech jab at City Hall has officially begun.

Staff at the large-scale site have confirmed that both the Oxford and the Pfizer vaccines are currently being used.

This means people in all age groups can now receive their vaccination at the venue on Malthouse Lane.

Read more: City Hall set to roll out Pfizer vaccine for under 40s

Around 900 people are being vaccinated daily from City Hall.

Capacity "is increasing all the time", a spokesperson confirmed, and slots are available for next week.

'Not too late' to book your jab

A spokesperson from Salisbury NHS Foundation Trust said: "If people are in the appropriate cohorts, then please book an appointment.

"We appreciate that at times the process can be frustrating but [we want to] encourage everyone to keep trying as new slots are being made available all the time.

"Even if they previously chose not to be vaccinated it's not too late to take up the offer, the team will be delighted to welcome them to the vaccination centre and can provide all the support they might need."

Two jabs

The decision to administer two different vaccines under the same roof came after the Government's announcement that people under the age of 40 should be offered a jab other than Oxford/AstraZeneca.

This is linked to stronger evidence linking the vaccine to rare blood clots.

Speaking to the Journal earlier this month, Fiona Hyett, Operational Director at City Hall, said: “We will have people aged 40 and above still coming through, some for their first doses but also second doses, so there’s that natural side by side synergy of needing to run two vaccines side by side.”

People aged 34 and over are now eligible for their Covid-19 jab.

Get more Salisbury news

You can also like our Facebook page and follow us on Twitter and Instagram to stay up to date.

If you want online news with fewer ads, unlimited access and reader rewards - plus a chance to support our local journalism - find out more about registering or a digital subscription.

Email with your comments, pictures, letters and news stories.